Alpha 2.0
Login Register
» Authors » Rachel A Elliott

Rachel A Elliott

Explore the profile of Rachel A Elliott including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 59
Citations 984
Followers 0
Related Specialties
Pharmacology
General Medicine
Public Health
Top 10 Co-Authors
Anthony J Avery
Katherine Payne
Mike Slade
Georgios Gkountouras
Matthew Franklin
Lukasz Tanajewski
Nick Barber
Sean P Gavan
Fiona Ng
Joy Llewellyn-Beardsley
Published In
Pharmacoeconomics
Pharm World Sci
Value Health
Trials
BMJ
Affiliations
Soon will be listed here.
Recent Articles
1.
Effectiveness and cost-effectiveness of online recorded recovery narratives in improving quality of life for people with psychosis experience (NEON Trial): a pragmatic randomised controlled trial
Slade M, Rennick-Egglestone S, Robinson C, Newby C, Elliott R, Ali Y, et al.
Lancet Reg Health Eur . 2024 Nov; 47:101101. PMID: 39507771
Background: The Narrative Experiences Online (NEON) Intervention provides self-managed web-based access to mental health recovery narratives (n = 659). We evaluated effectiveness and cost-effectiveness in improving quality of life for...
2.
Hearing and vision rehabilitation for people with dementia in five European countries (SENSE-Cog): a randomised controlled trial
Leroi I, Armitage C, Camacho E, Charalambous A, Connelly J, Constantinidou F, et al.
Lancet Healthy Longev . 2024 Oct; 5(11):100625. PMID: 39389083
Background: The effect of hearing and vision difficulties on the risk of developing dementia and worsening outcomes in people already living with dementia is well established. We evaluated the clinical...
3.
Estimating the economic effect of harm associated with high risk prescribing of oral non-steroidal anti-inflammatory drugs in England: population based cohort and economic modelling study
Camacho E, Penner L, Taylor A, Guthrie B, Avery A, Ashcroft D, et al.
BMJ . 2024 Jul; 386:e077880. PMID: 39048136
Objectives: To quantify prevalence, harms, and NHS costs in England of problematic oral non-steroidal anti-inflammatory drug (NSAID) prescribing in high risk groups. Design: Population based cohort and economic modelling study....
4.
The Relational Approach to Treating Self-Harm (RELATE): study protocol for a feasibility randomised controlled trial study of cognitive analytic therapy for adults who self-harm versus treatment at usual
Taylor P, Adeyemi I, Marlow K, Cottam S, Airnes Z, Hartley S, et al.
Pilot Feasibility Stud . 2024 Jul; 10(1):101. PMID: 39026281
Background: Self-harm is a prevalent behaviour that has a major detrimental impact on a person's life. Psychological therapies have the potential to help, but evidence of effective interventions remains limited....
5.
Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study
Mok P, Carr M, Guthrie B, Morales D, Sheikh A, Elliott R, et al.
BMJ . 2024 Apr; 385:e076268. PMID: 38631737
Objective: To investigate risks of multiple adverse outcomes associated with use of antipsychotics in people with dementia. Design: Population based matched cohort study. Setting: Linked primary care, hospital and mortality...
6.
Effectiveness and cost-effectiveness of online recorded recovery narratives in improving quality of life for people with non-psychotic mental health problems: a pragmatic randomized controlled trial
Slade M, Rennick-Egglestone S, Elliott R, Newby C, Robinson C, Gavan S, et al.
World Psychiatry . 2024 Jan; 23(1):101-112. PMID: 38214639
Narratives describing first-hand experiences of recovery from mental health problems are widely available. Emerging evidence suggests that engaging with mental health recovery narratives can benefit people experiencing mental health problems,...
7.
Intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: A subgroup analysis from the FLASH-UK study
Leelarathna L, Sutton C, Evans M, Neupane S, Rayman G, Lumley S, et al.
Diabet Med . 2023 Oct; 41(3):e15249. PMID: 37897112
Aims: The FLASH-UK trial showed lower HbA1c with intermittently scanned continuous glucose monitoring (isCGM), as compared with self monitoring of blood glucose (SMBG), in adults with type 1 diabetes and...
8.
Estimating the cost-effectiveness of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in England
Elliott R, Rogers G, Evans M, Neupane S, Rayman G, Lumley S, et al.
Diabet Med . 2023 Sep; 41(3):e15232. PMID: 37750427
Objective: We previously showed that intermittently scanned continuous glucose monitoring (isCGM) reduces HbA1c at 24 weeks compared with self-monitoring of blood glucose with finger pricking (SMBG) in adults with type...
9.
Organisational and student characteristics, fidelity, funding models, and unit costs of recovery colleges in 28 countries: a cross-sectional survey
Hayes D, Hunter-Brown H, Camacho E, McPhilbin M, Elliott R, Ronaldson A, et al.
Lancet Psychiatry . 2023 Sep; 10(10):768-779. PMID: 37739003
Background: Recovery colleges were developed in England to support the recovery of individuals who have mental health symptoms or mental illness. They have been founded in many countries but there...
10.
Differences Between Online Trial Participants Who Have Used Statutory Mental Health Services and Those Who Have Not: Analysis of Baseline Data From 2 Pragmatic Trials of a Digital Health Intervention
Rennick-Egglestone S, Newby C, Robinson C, Yeo C, Ng F, Elliott R, et al.
J Med Internet Res . 2023 Jun; 25:e44687. PMID: 37368471
Background: Digital health interventions (DHIs) are an established element of mental health service provision internationally. Regulators have positioned the best practice standard of evidence as an interventional study with a...